Myocardial perfusion imaging using a technetium-99m Sestamibi in asymptomatic and low risk for coronary artery disease patients with diagnosed systemic lupus erythematosus
تاریخ
2011نویسنده
Baharfard, N
Mohammad Kazem Shiroodi, Fotoohi, F
Samangooie, S
Isa Neshandar Asli, Eghtesadi-Araghi, P
Javadi, H
Semnani, S
Amini, A
Assadi, M
Metadata
نمایش پرونده کامل آیتمچکیده
Introduction: The aim of the present study was to evaluate technetium-99m sestamibi single photon emission tomography (SPECT) myocardial perfusion imaging (MPI) and its association with some clinical and laboratory parameters in an asymptomatic systemic lupus erythematosus (SLE) population. Materials and Methods : Twenty-one subjects with SLE and no suspected or documented coronary artery disease (CAD) accomplished myocardial perfusion imaging. Some SLE and CAD parameters were also evaluated in association with myocardial SPECT. Results: Twenty-one women with a diagnosis of SLE (mean age 36.9 ± 12.8) entered the study. All patients were in the low-risk category for CAD pretest; however, abnormal myocardial perfusion results were found in eight (38%) patients. Amongst the traditional CAD risk factors, there was a significant association between the presence of dyslipidemia and myocardial perfusion abnormalities (P= 0.047). However, we found no significant association between other traditional and SLE-specific risk factors. Conclusion: This study's significant finding was that asymptomatic CAD is common in SLE patients, even in those thought to be low risk for CAD and in the absence of cardiac symptoms. © The Author(s) 2010.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Evaluation of chemotherapy toxicity in acute lymphoblastic and Myelogenous Leukemia
Entezari-Maleki, T; Margedari, S; Gholami, K; Hadjibabaie, M; Oghazian, MB; Salamzadeh, J; Khoee, SH; Ghavamzadeh, A (2012)Background and Aims: Adverse drug reactions (ADRs) are one of the major leading causes of death in the world. This study was designed and conducted because of the importance of adverse events in the cancer treatment setting ... -
Comparison of existing disease activity indices in the follow-up of patients with Behçet's disease
Shahram, F; Khabbazi, A; Nadji, A; Ziaie, N; Banihashemi, AT; Davatchi, F (2009)The objective of this study was to determine the concordance between the Iranian Behçet's disease dynamic activity measure (IBDDAM) or the Behçet's disease current activity form (BDCAF) and expert physician global assessment ...